260 related articles for article (PubMed ID: 8616768)
1. Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities.
Perry A; Molberg K; Albores-Saavedra J
Cancer; 1996 Feb; 77(4):750-6. PubMed ID: 8616768
[TBL] [Abstract][Full Text] [Related]
2. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
[TBL] [Abstract][Full Text] [Related]
3. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).
Niederle B; Sebag F; Brauckhoff M
Langenbecks Arch Surg; 2014 Feb; 399(2):185-97. PubMed ID: 24297502
[TBL] [Abstract][Full Text] [Related]
4. C-cell hyperplasia in sporadic and familial medullary thyroid carcinoma.
Yadav M; Agrawal V; Pani KC; Verma R; Jaiswal S; Mishra A; Pandey R
Indian J Pathol Microbiol; 2018; 61(4):485-488. PubMed ID: 30303134
[TBL] [Abstract][Full Text] [Related]
5. [Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].
Ting S; Synoracki S; Schmid KW
Pathologe; 2015 May; 36(3):246-53. PubMed ID: 25898937
[TBL] [Abstract][Full Text] [Related]
6. C-cell hyperplasia and medullary thyroid microcarcinoma.
Albores-Saavedra JA; Krueger JE
Endocr Pathol; 2001; 12(4):365-77. PubMed ID: 11914470
[TBL] [Abstract][Full Text] [Related]
7. The pathology of preclinical medullary thyroid carcinoma.
Ashworth M
Endocr Pathol; 2004; 15(3):227-31. PubMed ID: 15640548
[TBL] [Abstract][Full Text] [Related]
8. ["Physiological" and "neoplastic" C-cell hyperplasia of the thyroid. Morphologically and biologically distinct entities?].
Hinze R; Gimm O; Brauckhoff M; Schneyer U; Dralle H; Holzhausen HJ
Pathologe; 2001 Jul; 22(4):259-65. PubMed ID: 11490939
[TBL] [Abstract][Full Text] [Related]
9. Immunostains for collagen type IV discriminate between C-cell hyperplasia and microscopic medullary carcinoma in multiple endocrine neoplasia, type 2a.
McDermott MB; Swanson PE; Wick MR
Hum Pathol; 1995 Dec; 26(12):1308-12. PubMed ID: 8522302
[TBL] [Abstract][Full Text] [Related]
10. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
11. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases.
Etit D; Faquin WC; Gaz R; Randolph G; DeLellis RA; Pilch BZ
Arch Pathol Lab Med; 2008 Nov; 132(11):1767-73. PubMed ID: 18976013
[TBL] [Abstract][Full Text] [Related]
13. C-cell hyperplasia and medullary thyroid carcinoma in the rat. An immunohistochemical and ultrastructural analysis.
DeLellis RA; Nunnemacher G; Bitman WR; Gagel RF; Tashjian AH; Blount M; Wolfe HJ
Lab Invest; 1979 Feb; 40(2):140-54. PubMed ID: 431034
[TBL] [Abstract][Full Text] [Related]
14. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
[TBL] [Abstract][Full Text] [Related]
15. Presurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing.
Pomares FJ; Rodríguez JM; Nicolás F; Sola J; Canteras M; Balsalobre M; Pascual M; Parrilla P; Tébar FJ
J Am Coll Surg; 2002 Nov; 195(5):630-4. PubMed ID: 12437249
[TBL] [Abstract][Full Text] [Related]
16. Distribution of calcitonin-containing parafollicular cells of the thyroid in patients with chronic lymphocytic thyroiditis: a clinical, pathological and immunohistochemical study.
Lukács G; Sápy Z; Gyóry F; Tóth V; Balázs G
Acta Chir Hung; 1997; 36(1-4):204-6. PubMed ID: 9408347
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the Significance of Prominent C Cells in the Thyroid.
Fuchs TL; Bell SE; Chou A; Gill AJ
Endocr Pathol; 2019 Jun; 30(2):113-117. PubMed ID: 30694510
[TBL] [Abstract][Full Text] [Related]
18. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions.
Komminoth P; Roth J; Saremaslani P; Matias-Guiu X; Wolfe HJ; Heitz PU
Am J Surg Pathol; 1994 Apr; 18(4):399-411. PubMed ID: 8141431
[TBL] [Abstract][Full Text] [Related]
19. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.
Kaserer K; Scheuba C; Neuhold N; Weinhäusel A; Vierhapper H; Haas OA; Niederle B
Am J Surg Pathol; 1998 Jun; 22(6):722-8. PubMed ID: 9630179
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry of medullary thyroid carcinoma and C-cell hyperplasia by an affinity-purified anti-human calcitonin antiserum.
Hayashida CY; Alves VA; Kanamura CT; Ezabella MC; Abelin NM; Nicolau W; Bisi H; Toledo SP
Cancer; 1993 Aug; 72(4):1356-63. PubMed ID: 8339225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
